Introduction
Deregulated Sonic Hedgehog (Shh) signaling is implicated in the initiation, progression and/or maintenance of many human tumors, including cutaneous basal cell carcinoma (BCC), pancreatic cancers and prostate cancers (Hooper and Scott, 2005) . Key effectors of Shh signaling include zinc-finger proteins of the Gli family. In mouse epidermal cells or in rat kidney epithelial cells immortalized with adenovirus E1A (i.e., RK3E cells), Gli1 rapidly induces transcription of Snail, a zinc-finger protein that represses transcription of E-cadherin and promotes the epithelial-mesenchymal transition (EMT) (Louro et al., 2002; Barrallo-Gimeno and Nieto, 2005; Li et al., 2006) . Snail short-hairpin RNAs (shRNAs) or a dominant-negative (DN) allele blocked transformation of RK3E cells by Gli1, whereas exogenous Snail cooperated with Gli1 to induce transformation (Li et al., 2006) . E-cadherin (E-cad) is a type I integral membrane protein that localizes to adherens junctions and mediates Ca 2 þ -dependent, cell-cell adhesion (Cavallaro and Christofori, 2004; Nelson and Nusse, 2004; Gumbiner, 2005; Brembeck et al., 2006) . The C terminus of E-cad is linked to a-catenin and the actin cytoskeleton through association with b-catenin. In addition to its role in cellcell adhesion, b-catenin is a nuclear effector of Wnt signaling, inducing cell proliferation and transformation. Wnt signals inhibit glycogen synthase kinase (GSK3b), which normally phosphorylates the N terminus of b-catenin and targets it for degradation (Nelson and Nusse, 2004; Bienz, 2005; Brembeck et al., 2006) . The increased b-catenin then translocates to the nucleus where it associates with the DNA-binding proteins Lef/ Tcf. In this complex, the C terminus of b-catenin mediates the transactivation of Wnt pathway targets such as Cyclin D1.
Participation of b-catenin in cell-cell adhesion or Wnt signaling is determined by competitive binding of b-catenin to a-catenin and the actin network versus Wnt signaling components in the cytoplasm (Gottardi and Gumbiner, 2004; Nelson and Nusse, 2004; Bienz, 2005; Gumbiner, 2005; Brembeck et al., 2006) . Switching of b-catenin from cell adhesion to Wnt signaling can be induced by tyrosine phosphorylation of b-catenin, which promotes binding to BCL9-2 instead of a-catenin. In response to Wnt signaling in the primitive streak, fibroblast growth factor induces an EMT through regulation of Snail and E-cad, leading to rapid accumulation of cytosolic b-catenin (Ciruna and Rossant, 2001 ). Loss of E-cad during tumor progression could likewise promote Wnt signaling (Nelson and Nusse, 2004; Bienz, 2005) . However, E-cad loss-of-function in tumor cells is not often associated with increased b-catenin signaling and specific contexts in which the cadherin-bound pool of b-catenin is released for signaling remain poorly understood (van de Wetering et al., 2001; Gottardi and Gumbiner, 2004; Nelson and Nusse, 2004; Gumbiner, 2005) .
The Hedgehog family member Indian Hedgehog can suppress Wnt-b-catenin signaling in colonic epithelial cells, and Gli1 may contribute to this effect (van den Brink et al., 2004; Akiyoshi et al., 2006) . However, in other contexts Wnt signaling can be a downstream effector of Shh. In Drosophila imaginal discs, wingless is directly regulated by the Gli homologue Ci (Von Ohlen et al., 1997) . In Xenopus animal caps, induction of Wnt8 and Wnt11 is important for Gli2-mediated alteration of the posterior mesoderm (Mullor et al., 2001) . Human BCCs have constitutive Shh pathway signaling and show increased levels of Wnt2b and Wnt5a and increased levels of nuclear b-catenin (Bonifas et al., 2001; El Bahrawy et al., 2003; Saldanha et al., 2004; Hooper and Scott, 2005) . As observed for Shh pathway genes such as Gli1, b-catenin promotes follicle-like tumors or BCCs in transgenic mice (Alonso and Fuchs, 2003; Nicolas et al., 2003) . In the current study, we identify E-cad as a selective suppressor of transformation by Gli1, identify a positive feedback loop in which Snail maintains Gli1 expression and suggest a model in which Gli1 acts through Wnts and Snail to induce the b-catenin switch during epithelial transformation.
Results

DN Tcf4 inhibits transformation by Gli1 but not by other genes
To investigate the role of E-cad and Wnt signaling in the cellular response to Gli1, we utilized in vitro transformation of immortalized rat kidney cells, an epithelial model previously used for analysis of mechanisms of transfor- E-cadherin suppresses Gli1 by sequestering b-catenin X Li et al mation by b-catenin, g-catenin, Notch and Jagged1 (Kolligs et al., 1999 (Kolligs et al., , 2000 Ascano et al., 2003) . Tcf alleles lacking the N-terminal, b-catenin-binding sequence, such as Tcf4
DN31
, act as DNs and effectively inhibit Wnt signaling (Kolligs et al., 1999 (Kolligs et al., , 2000 . Compared with parental RK3E cells, Gli1-induced foci in RK3E-Tcf4 DN31 were reduced by 85% (mean no. of foci/dish: RK3E-Tcf4
, 12.8; RK3E, 85.7; Figure 1a and b). Quantification was performed on stained dishes by counting foci >0.5 mm in diameter. As controls, ErbB2 induced 31.0 and 29.0 foci/dish, whereas H-Ras induced 93.0 and 97.0 foci/dish in RK3E and RK3E-Tcf4 DN31 , respectively (Figure 1a and b) . The inhibitory effect of Tcf4 DN31 on Gli1 in these cells was similar to that observed when activated b-catenin was the transforming agent (Kolligs et al., 1999) .
Rapid induction of multiple Wnts by Gli1
Wnt ligands such as Wnt2b are expressed in Gli1-transformed RK3E cells, in Gli1-induced skin tumors or in human BCCs (Bonifas et al., 2001; Mullor et al., 2001; Louro et al., 2002) . To temporally correlate Gli1 activity with Wnt transcript levels, we used RTOG10 cells, a clone of RK3E that contains a tetracycline (tet)-inducible Gli1 allele (Li et al., 2006) . Microarray analysis of these cells identified Wnt4 and Wnt7b as early responses to Gli1 (3 h, data not shown). By semi- Li et al., 2006) . Induction of Wnt4 was slight at 3 h and prominent at 6 h, whereas Wnt2b was induced between 3 and 6 h (Louro et al., 2002) . These Wnts were also increased in Gli-C cells, a Gli1-transformed clone of RK3E ( Figure 1c , lanes 5-6) .
Gli1 induces the accumulation of transcriptionally active b-catenin in cell nuclei
To determine whether or not Gli1 can alter the localization of b-catenin, we analysed cells by immunofluorescence. In RK3E cells, b-catenin was at the cell periphery and did not appreciably overlap the nuclei (Figure 2a , b-cat/4,6-diamidino-2-phenylindole (DAPI)) or the actin cytoskeleton (b-cat/phalloidin). In contrast, Gli-C cells showed reduced staining at the cell periphery and prominent, diffuse staining of the cytoplasm and nucleus, similar to cells with activated Wnt signaling (Kolligs et al., 2000) ( Figure 2a , lower panels). We used immunoblot analysis to analyse the nuclear and cytoplasmic pools of b-catenin (Figure 2b ). Compared with RK3E cells, Gli-C cells showed increased nuclear b-catenin consistent with the immunostaining analysis above. Overall levels of b-catenin were similar in these two lines (data not shown).
To test whether this increased nuclear b-catenin is active in transcription, we used a Tcf-responsive reporter. Tcf activity was observed in Gli-C cells but not in RK3E cells or Notch1-transformed cells, a control (Figure 2c ). In addition, transfection of HEK293 cells with pcDNA3.1-HA-Gli1 induced Tcf activity (Figure 2d ).
Nuclear b-catenin is increased in human BCCs (El Bahrawy et al., 2003; Saldanha et al., 2004) . We stained sections of BCC-like lesions induced by tet on Gli1 (Li et al., 2006) using an antibody to the active, unphosphorylated form of b-catenin. The superficial epithelium stained weakly, whereas the more infiltrative basaloid cells stained prominently (Figure 2e ). This pattern is opposite to the pattern of E-cad in these lesions (Li et al., 2006) . As Gli1 is uniformly induced by tet in the epidermis (Huang et al., 2005; Li et al., 2006) , the apparent restriction of Gli1 effects to infiltrating cells may reflect post-translational regulation. In contrast, antibody to total b-catenin uniformly stained the tumor cells (not shown).
Enforced expression of E-cad suppresses Gli1-mediated transformation RK3E cells stably transduced with a mouse E-cad retroviral vector showed increased expression of a species that comigrates with the endogenous protein ( Figure 3a) . RK3E-E-cad cells were similar to vector cells in cell morphology and growth rate (not shown). To assess the effect on transformation, we co-transfected vectors for Gli1 or ErbB2 with E-cad or empty vector (Figure 3b and c) . E-cad suppressed Gli1-mediated transformation by 83%, (mean no. of foci/ dish: Gli1 þ Vector, 17.8; Gli1 þ E-cad, 3.0), but showed no effect on ErbB2 (ErbB2 þ Vector, 16.0; ErbB2 þ E-cad, 16.7). As observed for Tcf4
DN31
, E-cad functions as a selective suppressor of transformation by Gli1. 
E-cadherin suppresses
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E-cad loss-of-function promotes transformation by Gli1
shRNAs that target rat E-cad were expressed in RK3E cells (see Supplementary Tables 1 and 2 ). Immunoblot analysis of early passage, G418-resistant cells derived from pooled colonies showed that E-cad sh1 or E-cad sh2 suppressed E-cad (Figure 4a ). Based upon the size and number of colonies obtained using the E-cad shRNAs versus control (not shown), E-cad knockdown had little effect on the cell growth rate, as previously shown using Snail vector (Li et al., 2006) . Whether these E-cad-low cells show other properties of malignant cells in vitro or in vivo has not been studied. When co-transfected with Gli1 or ErbB2, E-cad sh1 or E-cad sh2 promoted the outgrowth of Gli1-transformed cells (mean no. of foci/dish: Gli þ pSi Ctl , 21.6; Gli1 þ E-cad sh1 , 51.2; Gli1 þ E-cad sh2 , 43.4; Figure 4b and c). In contrast, the efficiency of ErbB2-induced transformation showed little change (Figure 4b and c) .
Snail loss-of-function is rescued by downregulation of Ecad Snail shRNAs induce E-cad in Gli-C cells and block Gli1 transformation (Li et al., 2006) . When co-transfected with Sna sh3 vector (Li et al., 2006) , E-cad sh2 and E-cad sh1 promoted Gli1 transformation by three-fold and fivefold relative to pSi Ctl (mean number of foci/dish:
, 30.8; Figure 5a and b). Thus, suppression of E-cad is a major mechanism by which Snail contributes to transformation by Gli1.
The transformation suppressor activity of E-cad requires b-catenin binding E-cad
DbÀcat , containing a 35 amino-acid deletion in the C terminus, fails to interact with b-catenin but retains the cell-cell adhesion function (Figure 6a) (Gottardi et al., 2001 ). E-cad cyto is a fusion of the E-cad cytoplasmic domain to the extracellular and transmembrane domains of the IL2R (Gottardi et al., 2001) . Similar constructs are inactive in cell-cell adhesion. In SW480 colorectal carcinoma cells, E-cad cyto inhibits Wnt signaling and blocks cell growth, perhaps by trapping b-catenin in the cytosol.
Unlike wild-type (WT) E-cad, E-cad DbÀcat did not block transformation by Gli1 (mean no. of foci/dish: Gli1 þ Vector, 21.0; Gli1 þ E-cad DbÀcat , 20.6; Gli1 þ E-cad, Figure 6b and c), indicating that b-catenin binding is required. Unexpectedly, E-cad cyto induced 2.9-fold more foci when co-transfected with Gli1 (mean foci/ dish, 61.2 versus 21.0; Figure 6b and c). E-cad cyto did not promote cell growth independent of Gli1, as indicated by the colony size and number and cell morphology of transfected cells (Figure 6d and e).
Gli1 activity correlates with nuclear localization of b-catenin
We next determined how regulators of Gli1 transformation affect b-catenin (Figure 7a ). RK3E cells were stably transduced with E-cad, E-cad cyto , Snail or a control retrovirus ((À) Gli1), and then transduced with a Gli1 retrovirus (( þ ) Gli1). Nuclear and cytosol extracts were prepared 14 days later. Gli1 promoted nuclear localization of b-catenin in settings where it is active in transformation, including vector cells, E-cad cyto cells and Snail cells (Figure 7a , compare upper and middle panels, lanes 5, 7 and 8). In E-cad cells, where Gli1 activity is suppressed, nuclear localization of b-catenin was not increased (Figure 7a , compare upper and middle panels, lane 6). E-cad cyto and Snail, which augment transformation by Gli1, also promoted nuclear expression of b-catenin (Figure 7a , compare lanes 5, 7 and 8, upper panels). In the absence of Gli1, b-catenin levels were similar in all lines except for E-cad cyto cells, which accumulated b-catenin in the cytoplasm Thus, E-cad cyto increased the signaling-competent pool of b-catenin independent of Gli1. Unexpectedly, Snail cells showed increased Gli1 in the nucleus and cytoplasm (Figure 7a, lower panel, lanes 4 and 8) .
By semi-quantitative RT-PCR, the Wnt targets Cyclin D1 and Twist2 were induced in Gli-C cells, whereas c-Myc was diminished (Figure 7b) . Indeed, c-Myc is not upregulated by b-catenin in RK3E cells (Kolligs et al., 1999) and the expression profiles of RK3E cells transformed by c-Myc or Gli1 are distinct (Louro et al., 2002) . As g-catenin induces c-Myc in RK3E (Kolligs et al., 2000) , our results suggest that Gli1 signals through b-catenin rather than g-catenin.
Discussion
In the current study, we identified regulation of E-cad as a mechanism by which Snail promotes transformation by Gli1. This conclusion was supported by the ability of E-cad shRNAs to rescue Gli1 activity following Snail knockdown. E-cad suppresses Gli1 activity by binding to b-catenin. b-catenin activity or nuclear localization was promoted by Gli1 in several settings and was E-cadherin suppresses Gli1 by sequestering b-catenin X Li et al required for transformation by Gli1, but not by ErbB2 or H-Ras, as indicated by use of DN Tcf4. This result was supported by the ability of E-cad cyto to stabilize b-catenin and to promote Gli1-mediated transformation. As Gli1 fails to completely suppress E-cad during epithelial transformation, other mechanisms that suppress E-cad might cooperate with Gli1 during tumor progression.
Loss of E-cad expression is observed in human carcinomas, including BCC (Cavallaro and Christofori, 2004; Li et al., 2006) . Although E-cad's role as an invasion suppressor is well-established (Cavallaro and Christofori, 2004; Brembeck et al., 2006) , its ability to suppress tumor cell growth or oncogene-induced transformation in vitro is less studied.
The Shh and Wnt pathways interact at multiple levels and coordinate developmental transitions in mammals (Nusse, 2003) . GSK3b acts in the Wnt pathway but also regulates Hedgehog signaling, including the Gli1-target gene Snail (Zhou et al., 2004; Bachelder et al., 2005; Yook et al., 2005; Price, 2006) . Wnt and Shh signals play distinct roles in the development of hair follicles in the skin (Alonso and Fuchs, 2003; Silva-Vargas et al., 2005; Brembeck et al., 2006) . Wnt signals initiate hair bud and follicle formation, whereas Shh signals potentiate the Wnt effects and are required for the subsequent proliferation/migration of bud or follicle cells.
Our studies support the idea that Shh-Gli signaling can feed back into the Wnt pathway (Figure 7c ). In addition to directly inducing Snail transcription (Louro et al., 2002), Gli1 induces transcription of at least three Wnt family members, Wnt2b, Wnt4 and Wnt7b. As Snail alone does not induce nuclear localization of bcatenin, coinduction of Snail and Wnts by Gli1 may synergize to switch b-catenin from cell adhesion to nuclear signaling. Wnt signaling to GSK3b can further promote Snail transcription and stabilize the protein (Zhou et al., 2004; Bachelder et al., 2005; Yook et al., 2005) . Snail promoted expression of Gli1 in our studies, probably by a post-transcriptional mechanism. This induction generates two positive feedback loops: Gli1-Snail-Gli1 and Gli1-Wnt-GSK3b-Snail-Gli1 (Figure 7c) .
Wnt-mediated inhibition of GSK3b activates the mammalian target of rapamycin (mTOR) kinase, identifying rapamycin and related inhibitors of mTOR as antagonists of malignant cells with active Wnt signaling (Inoki et al., 2006) (Figure 7c ). This signaling may explain how Gli1 activates mTOR and how mTOR inhibitors block transformation by Gli1, as we showed previously . In summary, our studies identify Shh-Gli1-expressing epithelial cells as a setting in which Snail-induced EMT and increased cell growth are linked by the dual roles of b-catenin.
Materials and methods
Expression vectors
WT E-cad (Genbank X06115) was released from pEM2 (Nagafuchi et al., 1987) by digestion with StuI and EcoRV. The blunted 3.3 kb fragment was ligated to BstXI adaptors and then inserted into the same site of the MMLV retroviral vector pCTV3B, which confers resistance to hygromycin. Ecad cyto and E-cad DbÀcat plasmids were provided by Cara Gottardi (Northwestern University, Chicago, IL, USA) and the inserts were cloned into the pBABE-puro. , containing a hairpin sequence without similarity to mammalian cDNAs, were reported previously (Li et al., 2006) .
Cell culture and transfection
To generate RK3E cells stably expressing E-cad, E-cad cyto and E-cad DbÀcat , retroviral transduction and antibiotic selection was performed as described (Foster et al., 1999) . Vector cells and Snail cells were generated previously by the same methods using pBABE-puro or pBABE-puro-Snail (Li et al., 2006) . To introduce Gli1, each of these lines were transduced with the neo vector pLJD-HA-Gli1 (Louro et al., 2002) . RK3E-Tcf4 DN31 cells were generated previously by Fearon and colleagues by retroviral transduction of RK3E cells, followed by mass selection in G418.
Transformation assays were performed following lipidmediated transfection of 10.0 mg of plasmid into 70% confluent cells (Li et al., 2006) . Cells were fixed and incubated in Wright's stain at 2-3 weeks post-transfection. Expression vectors for Gli1 (pLTR6) (Ruppert et al., 1991) , ErbB2 (Li et al., 2006) or H-Ras (pHO6T1) were transfected directly into RK3E or RK3E-Tcf4 DN31 cells. For cotransfection experiments, 2.0 mg of Gli1 or ErbB2 vector were cotransfected with a total of 8.0 mg of the indicated plasmid(s). For colony morphology analysis, cells were plated in 10 cm tissue culture dishes and selected for 9 days in G418 (400 mg/ml) or puromycin (80 mg/ml).
For analysis of shRNA-mediated E-cad knockdown, RK3E cells were transfected by electroporation of pSilencer constructs (protocol available upon request). Populations of cells were selected for 2 weeks in 400 mg/ml of G418 and whole cell extracts were prepared for immunoblot analysis.
Subcellular fractionation and immunoblot analysis
Fractionation was performed by sequential extraction of cytosolic and nuclear proteins in non-ionic detergent as described (Jian et al., 2006) . Antibodies to b-catenin (BD Biosciences, San Jose, CA, USA, no. 610153, used at 0.5 mg/ ml), b-tubulin (b-tub) (Sigma-Aldrich, St Louis, MO, USA, no. T0198, 0.55 mg/ml), Lamin B1 (GeneTex, San Antonio, TX, USA, no. GTX16048, 0.1 mg/ml) and Gli1 (Li et al., 2006) were used to detect proteins. For analysis of E-cad, whole cell extracts were prepared by application of hot Laemlli buffer to cells. Sodium dodecyl sulfate extracts were quantitated by amido black staining of spotted samples. E-cad antibody (BD Biosciences no. 610181) was used at 0.1 mg/ml and b-actin antibody (Sigma no. A5316) was used at 0.26 mg/ml. Bound antibodies were detected by chemiluminescence (Pierce, Rockford, IL, USA).
Other materials and methods Descriptions of the luciferase reporter assays, mRNA expression assays, immunostaining assays and digital imaging are available at the Oncogene website as Supplementary Information.
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